Literature DB >> 22348456

Combined extractives of red yeast rice, bitter gourd, chlorella, soy protein, and licorice improve total cholesterol, low-density lipoprotein cholesterol, and triglyceride in subjects with metabolic syndrome.

I-Te Lee1, Wen-Jane Lee, Ching-Min Tsai, Ih-Jen Su, Hsien-Tung Yen, Wayne H-H Sheu.   

Abstract

In this study, we aimed to examine the effects of a plant-extractive compound on lipid profiles in subjects with metabolic syndrome. We hypothesized that extractives from red yeast rice, bitter gourd, chlorella, soy protein, and licorice have synergistic benefits on cholesterol and metabolic syndrome. In this double-blinded study, adult subjects with metabolic syndrome were randomized to receive a plant-extractive compound or a placebo treatment for 12 weeks. Both total cholesterol (5.4 ± 0.8 to 4.4 ± 0.6 mmol/L, P < .001) and low-density lipoprotein cholesterol (3.4 ± 0.7 to 2.7 ± 0.5 mmol/L, P < .001) were significantly reduced after treatment with the plant extractives, and the magnitudes of reduction were significantly greater than in the placebo group (-1.0 ± 0.6 vs 0.0 ± 0.6mmol/L, P < .001; -0.7 ± 0.6 vs 0.0 ± 0.6 mmol/L, P < .001). The reduction in the fasting triglycerides level was significantly greater in the plant-extractive group than in the placebo group (-0.5 ± 0.8 vs -0.2 ± 1.0 mmol/L, P = .039). There was also a significantly greater reduction in the proportion of subjects with hypertensive criteria in the plant-extractive group than in the placebo group (P = .040). In conclusion, the plant extractives from red yeast rice, bitter gourd, chlorella, soy protein, and licorice were effective in reducing total and low-density lipoprotein cholesterol. The plant extractives also showed potential for reducing triglyceride and normalizing blood pressure. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22348456     DOI: 10.1016/j.nutres.2011.12.011

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  6 in total

1.  Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Authors:  Arrigo F G Cicero; Alessandro Colletti; Gani Bajraktari; Olivier Descamps; Dragan M Djuric; Marat Ezhov; Zlatko Fras; Niki Katsiki; Michel Langlois; Gustavs Latkovskis; Demosthenes B Panagiotakos; Gyorgy Paragh; Dimitri P Mikhailidis; Olena Mitchenko; Bernhard Paulweber; Daniel Pella; Christos Pitsavos; Željko Reiner; Kausik K Ray; Manfredi Rizzo; Amirhossein Sahebkar; Maria-Corina Serban; Laurence S Sperling; Peter P Toth; Dragos Vinereanu; Michal Vrablík; Nathan D Wong; Maciej Banach
Journal:  Arch Med Sci       Date:  2017-08-04       Impact factor: 3.318

Review 2.  Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons.

Authors:  Seema Patel
Journal:  World J Microbiol Biotechnol       Date:  2016-04-02       Impact factor: 3.312

3.  Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.

Authors:  Isabel De Castro-Orós; Rosa Solà; Rosa María Valls; Angel Brea; Pilar Mozas; Jose Puzo; Miguel Pocoví
Journal:  PLoS One       Date:  2016-03-25       Impact factor: 3.240

Review 4.  Atheroprotective Effects of Glycyrrhiza glabra L.

Authors:  Yuliya V Markina; Tatiana V Kirichenko; Alexander M Markin; Irina Y Yudina; Antonina V Starodubova; Igor A Sobenin; Alexander N Orekhov
Journal:  Molecules       Date:  2022-07-22       Impact factor: 4.927

5.  A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia.

Authors:  Yinhua Li; Long Jiang; Zhangrong Jia; Wei Xin; Shiwei Yang; Qiu Yang; Luya Wang
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

6.  Physicochemical and Consumer Acceptance of Tofu Supplemented with Licorice Powder.

Authors:  Jun Ho Lee; Han San Jung
Journal:  Prev Nutr Food Sci       Date:  2017-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.